MeHow Innovative Ltd (301363) Fair Value & Analysis
Healthcare · CN · Market cap 14.6B CNY
Analysis
MeHow Innovative Ltd (301363) currently trades at ¥19.88, while our model-based Fair Value estimate is ¥6.98 — implying the stock looks roughly 64.9% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).
About the company
MeHow Innovative Ltd. designs, develops, manufactures, and sells precision medical device components and products in China and internationally. The company primarily provides home ventilators, precision molds and automation equipment, surgical instruments, etc. It also offers variable dose pen, auto injector, auto secure dose pen; microfluidic solutions and laboratory consumables, such as cuvette, PCR tube, 96-well plates, freezing tubes, culture dish and bottle, suction head, and vacutainer; cardiovascular products, including electrophysiology catheter solutions, ablation catheter, high density mapping catheter, and intracardiac echocardiography; surgical solutions, such as ultrasonic scalpels, staplers, ligating clips, sterile-grade/implant-grade injection components, micro precision equipment components, automated assembly, and others. In addition, the company offers ophthalmology and ENT consumables, phacoemulsification disposables, IOL delivery systems, and hearing aids and coc…
Open the full interactive analysis →
Similar stocks
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.